STSS - Kewajiban jangka dawa marang modal sharpstechnology.com

Simbol lan logo merek Sharps Technology (STSS)

The price action of Sharps Technology, Inc. (STSS) on GURU.Markets illustrates the brand's ambitions to implement next-generation safety syringes. Sharps Technology, Inc. (STSS) relies on significant pricing power by minimizing medication waste, which renders clinic demand inelastic. However, financial stability stands at 0.00, as innovation costs and a lack of profitability lead to depleted reserves and a search for external financing.

Sharps Technology (STSS): Utang jangka dawa marang modal saka 28.04.2023 nganti 28.05.2026
Barang utama Sharps Technology Inc

For Sharps Technology, Inc. (STSS), which implements innovative safety standards for injection systems, the balance between debt and equity determines the sustainability of investments in high-tech laboratories. Analyzing the long-term debt load chart on GURU.Markets, an investor assesses the proportion of loans with maturities exceeding one year relative to shareholders' equity, which helps identify the risk of excessive leverage and the probability of cash flow gaps amid rising interest rates.

Analisis pesaing

Rasio utang jangka dawa marang ekuitas Intuitive Surgical, Inc.|Danaher Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Becton Dickinson & Company (BDX)|STE - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal westpharma.com WST|Utang jangka dawa marang modal BAX (Baxter)|MASI - Rasio tanggungan utang jangka dawa marang modal|STVN (Stevanato) - Utang jangka dawa marang modal|Teleflex Corp (TFX) - Rasio utang jangka dawa marang ekuitas|MMSI (Merit Medical Systems) - Utang jangka dawa marang modal|Utang jangka dawa marang modal NVST|Utang jangka dawa marang ekuitas ICU Medical (ICUI)|Utang jangka dawa marang ekuitas Dentsply Sirona Inc XRAY|Rasio utang jangka dawa marang ekuitas LeMaitre|Koefisien utang jangka dawa marang modal AtriCure Medical ATRC|Utang jangka dawa marang modal STAA (STAAR Surgical Company)|NAGE: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ZimVie|ANGO (AngioDynamics Inc) - Rasio utang jangka dawa marang modal|CERS: Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Teknova Inc (TKNO)|Rasio utang jangka dawa marang ekuitas Monogram Technologies|Rasio silihan jangka dawa marang modal INFU (infusystem.com)|Utang jangka dawa marang ekuitas Utah Medical Products, Inc.|KRMD - Koefisien utang jangka dawa marang modal|Nyxoah, S.A. - Rasio utang jangka dawa marang ekuitas|MBOT: Utang jangka dawa marang modal|PDEX (Pro-Dex, Inc.) - Utang jangka dawa marang ekuitas|zentek.com (ZTEK) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal ELUT (Elutia)|Kewajiban jangka dawa marang modal MLSS|Utang jangka dawa marang ekuitas NEXGEL, Inc NXGL|Rasio utang jangka dawa marang modal retractable.com RVP|Rasio utang jangka dawa marang ekuitas Harvard Bioscience, Inc. (HBIO)|femasys.com - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas MHUA (Meihua Medical)|POAI: Rasio tanggungan utang jangka dawa marang modal|callanjmb.com - Utang jangka dawa marang ekuitas|Atrion Corporation Inc. (ATRI) - Rasio tanggungan utang jangka dawa marang modal|NURO - Utang jangka dawa marang modal